Liaoning He Eye Hospital Group Co. LTD. Total Liabilities
Liaoning He Eye Hospital Group Co. LTD. total liabilities. Based on the latest financial reports, Liaoning He Eye Hospital Group Co. LTD. (301103) has total liabilities worth CN¥290.48 Million CNY (≈ $42.51 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301103 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Liaoning He Eye Hospital Group Co. LTD. (2019–2025)
Total liabilities of Liaoning He Eye Hospital Group Co. LTD. from 2019 to 2025. This chart illustrates how Liaoning He Eye Hospital Group Co. LTD.'s total liabilities have evolved over time, based on quarterly financial data.
Liaoning He Eye Hospital Group Co. LTD. Competitors by Total Liabilities
The table below lists competitors of Liaoning He Eye Hospital Group Co. LTD. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Apon Medical Technology Co Ltd Class A
SHE:300753
|
China | CN¥153.56 Million |
|
Tharisa plc
JSE:THA
|
South Africa | ZAC385.86 Million |
|
Cuckoo Homesys Co Ltd
KO:284740
|
Korea | ₩312.33 Billion |
|
CW Enerji SA
IS:CWENE
|
Turkey | TL20.29 Billion |
|
Guangdong Huafeng New Energy Technology Co Ltd
SHE:002806
|
China | CN¥844.02 Million |
|
Groenlandsbanken AS
CO:GRLA
|
Denmark | Dkr9.93 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$6.45 Billion |
|
SF Urban Properties AG
SW:SFPN
|
Switzerland | CHF513.38 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Liaoning He Eye Hospital Group Co. LTD.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Liaoning He Eye Hospital Group Co. LTD..
Liquidity & Leverage Metrics
Liaoning He Eye Hospital Group Co. LTD. Total Liabilities Ratios Explained
Liaoning He Eye Hospital Group Co. LTD. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Liaoning He Eye Hospital Group Co. LTD.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Liaoning He Eye Hospital Group Co. LTD. (2019–2025)
The table below shows the annual total liabilities of Liaoning He Eye Hospital Group Co. LTD. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥297.47 Million ≈ $43.53 Million |
-13.95% |
| 2024-12-31 | CN¥345.71 Million ≈ $50.59 Million |
-15.96% |
| 2023-12-31 | CN¥411.36 Million ≈ $60.19 Million |
-4.39% |
| 2022-12-31 | CN¥430.24 Million ≈ $62.96 Million |
+15.82% |
| 2021-12-31 | CN¥371.48 Million ≈ $54.36 Million |
-4.19% |
| 2020-12-31 | CN¥387.72 Million ≈ $56.73 Million |
+203.69% |
| 2019-12-31 | CN¥127.67 Million ≈ $18.68 Million |
-- |
About Liaoning He Eye Hospital Group Co. LTD.
Liaoning He Eye Hospital Group Co., LTD., together with its subsidiaries, provides ophthalmological and optometry services to patients with eye diseases in China. The company offers treatment for common blinding eye diseases, including cataracts, glaucoma, and vitreoretinal disorders; specialized treatments, such as dry eye and traditional Chinese medicine; and optometry services, including optic… Read more